E-mail

E-mail a Wiley Online Library Link

M. D. Stegall, T. Diwan, S. Raghavaiah, L. D. Cornell, J. Burns, P. G. Dean, F. G. Cosio, M. J. Gandhi, W. Kremers and J. M. Gloor Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients American Journal of Transplantation 11

Version of Record online: 22 SEP 2011 | DOI: 10.1111/j.1600-6143.2011.03757.x

This study demonstrates that the blockade of terminal complement activation with the C5-specific antibody eculizumab decreases the incidence of early antibody-mediated rejection in living donor renal transplant recipients who have high levels of donor specific alloantibody. See editorial by Woodle and Baldwin on page 2277.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH